METHOD FOR REDUCING NEUTROPENIA Russian patent published in 2021 - IPC A61K31/337 A61K31/437 A61K31/496 A61K31/704 A61K33/243 A61P7/00 

Abstract RU 2760348 C2

FIELD: medicine.

SUBSTANCE: present invention relates to the field of medicine, namely to a method for reducing neutropenia in a subject including injection of plinabulin or its pharmaceutically acceptable salt to a subject who needs it, while the specified neutropenia is caused by injection of the first chemotherapeutic composition containing one or more chemotherapeutic agents, where the specified chemotherapeutic composition does not contain taxan, or the specified neutropenia is cased by radiation therapy, where the specified one or more chemotherapeutic agents are selected from a group consisting of cyclophosphamide, ifosamide, cisplatin, carboplatin, oxaliplatin, nedaplatin, triplatin tetranitrate, phenantriplatin, picoplatin, satraplatin, topotecan, irinotecan, doxorubicin, epirubicin, daunorubicin, valrubicin and their pharmaceutically acceptable salts.

EFFECT: present invention provides for obtaining therapeutic agents that contribute to reducing neutropenia caused by cancer therapy.

22 cl, 12 dwg, 11 ex, 14 tbl

Similar patents RU2760348C2

Title Year Author Number
COMPOSITION AND METHOD FOR REDUCING THROMBOCYTOPENIA BY INTRODUCING PLINABULIN 2019
  • Khuan, Lan
  • Mokhanlal, Ramon
  • Llojd, Dzhordzh Kennet
RU2808652C2
NEUTROPENIA REDUCTION METHOD 2018
  • Mokhanlal, Ramon
  • Khuan, Lan
  • Llojd, Dzhordzh Kennet
RU2790989C2
COMPOSITION AND METHOD OF REDUCING CHEMOTHERAPY-INDUCED NEUTRPENIA BY ADMINISTRATION OF PLINABULIN AND G-CSF AGENT 2019
  • Mokhanlal, Ramon
  • Khuan, Lan
  • Llojd, Dzhordzh, Kennet
RU2798103C2
USE OF THE PLINABULIN IN COMBINATION WITH THE IMMUNE RESPONSE CONTROL POINT INHIBITORS 2016
  • Khuan Lan
  • Li Gloriya Tsi-Ji
RU2723021C2
TREATMENT OF CANCER BY COMBINATION OF PLINABULIN AND TAXANE 2013
  • Khuan Lan
RU2662298C2
METHOD FOR TREATING A BRAIN TUMOR 2016
  • Khuan, Lan
RU2728796C2
COMPOSITIONS CONTAINING TUCARESOL OR ANALOGUES THEREOF 2017
  • Khuan Lan
  • Mokhanlal Ramon
  • Llojd Dzhordzh Kennet
RU2753543C1
COMBINATION AND METHODS FOR INTRODUCING THERAPEUTIC AGENTS AND COMBINED THERAPY 2006
  • Disehj Nejl P.
  • Soon-Shiong Patrik
RU2452482C2
COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID 2011
  • Moneo Okanja Viktorija
  • Santamarija Nunes Khema
  • Garsia Fernandes Luis Fransisko
  • Galmarini Karlos Marija
  • Gilen Navarro Marija Khose
  • Aviles Marin Pablo Manuel
RU2605335C2
METHODS OF APPLYING SNS-595 FOR TREATMENT OF SUBJECTS WITH ONCOLOGIC DISEASES WITH REDUCED BRCA2 ACTIVITY 2010
  • Khotin Rejchal Eh.
  • Foks Dzhudit A.
RU2558835C2

RU 2 760 348 C2

Authors

Khuan, Lan

Llojd, Dzhordzh Kennet

Mokhanlal, Ramon

Dates

2021-11-24Published

2017-06-05Filed